FDA Import Refusal AEK-9198796-4/10002/1 — LILLY CORPORATE CENTER
The FDA refused shipment AEK-9198796-4/10002/1 from LILLY CORPORATE CENTER (United States Outlying Islands) on Dec 31, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Dec 31, 2025
- Country
- United States Outlying Islands
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75